• BP’s (BP) Overweight Rating Reiterated at Morgan Stanley

    Morgan Stanley reaffirmed their overweight rating on shares of BP (LON:BP – Free Report) in a research note published on Tuesday, Marketbeat Ratings reports. Other research analysts have also recently issued research reports about the stock. AlphaValue cut shares of BP to a reduce rating in a research report on Monday, February 12th. Barclays reaffirmed […]

  • Paragon 28’s (FNA) “Overweight” Rating Reiterated at Piper Sandler

    Paragon 28 (NYSE:FNA – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Piper Sandler in a research note issued to investors on Thursday, Benzinga reports. They presently have a $15.00 target price on the stock, down from their prior target price of $18.00. Piper Sandler’s price objective indicates a potential […]

  • Applied Materials (NASDAQ:AMAT) Given New $240.00 Price Target at JPMorgan Chase & Co.

    Applied Materials (NASDAQ:AMAT – Free Report) had its price target raised by JPMorgan Chase & Co. from $230.00 to $240.00 in a research note released on Friday morning, Benzinga reports. The firm currently has an overweight rating on the manufacturing equipment provider’s stock. A number of other analysts also recently issued reports on AMAT. Deutsche […]

  • Nicholas Investment Partners LP Sells 11,930 Shares of JPMorgan Chase & Co. (NYSE:JPM)

    Nicholas Investment Partners LP cut its position in JPMorgan Chase & Co. (NYSE:JPM) by 37.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,967 shares of the financial services provider’s stock after selling 11,930 shares during the quarter. Nicholas Investment Partners LP’s […]

  • Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines

    Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards Accelerates potential for development of a novel flu-COVID-19 combination product based on authorized vaccines with demonstrated efficacy and tolerability, potentially offering patients...

  • Aqua Metals (NASDAQ:AQMS) Rating Reiterated by HC Wainwright

    HC Wainwright reissued their buy rating on shares of Aqua Metals (NASDAQ:AQMS – Free Report) in a research note released on Thursday morning, Benzinga reports. The brokerage currently has a $4.00 price objective on the business services provider’s stock. HC Wainwright also issued estimates for Aqua Metals’ FY2027 earnings at $0.09 EPS. Separately, Benchmark reiterated […]

  • US and Japan sign agreement to co-develop hypersonic interceptor

    The Japanese government has flagged hypersonic missile defense as an urgent

  • Truist Financial (NYSE:TFC) Rating Reiterated by Evercore ISI

    Truist Financial (NYSE:TFC – Get Free Report)‘s stock had its “in-line” rating reiterated by research analysts at Evercore ISI in a report issued on Thursday, MarketBeat.com reports. They presently have a $44.00 price target on the insurance provider’s stock. Evercore ISI’s price objective points to a potential upside of 11.48% from the company’s current price. […]

  • Stephens Reaffirms Overweight Rating for Cheesecake Factory (NASDAQ:CAKE)

    Cheesecake Factory (NASDAQ:CAKE – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Stephens in a note issued to investors on Thursday, Benzinga reports. They presently have a $44.00 price objective on the restaurant operator’s stock. Stephens’ price target suggests a potential upside of 16.87% from the company’s previous close. Several […]

  • Boxlight’s (BOXL) Buy Rating Reiterated at HC Wainwright

    Boxlight (NASDAQ:BOXL – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently have a $2.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 222.58% from the stock’s previous close. HC […]

  • Stephens Reaffirms “Overweight” Rating for Chuy’s (NASDAQ:CHUY)

    Chuy’s (NASDAQ:CHUY – Get Free Report)‘s stock had its “overweight” rating restated by stock analysts at Stephens in a research note issued to investors on Friday, Benzinga reports. They currently have a $40.00 target price on the restaurant operator’s stock. Stephens’ target price would suggest a potential upside of 42.35% from the company’s current price. […]

  • Sandstorm Gold's (SAND) Buy Rating Reiterated at HC Wainwright

    HC Wainwright restated a "buy" rating and set a $11.00 target price on shares of Sandstorm Gold in a report on Monday.